85-5433-33　Aclarubicin (Aclacinomycin A) 5mg　CAS No:57576-44-0　440910

特徴

• Aclarubicin (Aclacinomycin A) is an anthracycline antibiotic. It is used in the treatment of cancer. Aclarubicin A, an anthracycline drug, specific inhibitor of the 20S proteasome chymotrypsin-like activity.
• Synonyms:(1R,2R,4S)-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester; [1R-(1α,2β,4β)]-2-Ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic Acid Methyl Ester; Aclacinomycin A; Aclacur; Antibiotic 3082A; Antibiotic 77-3082A; Antibiotic MA 144A1; Jaclacin; NSC 208734
• Molecular Formula:C₄₂H₅₃NO₁₅
• Molecular Weight:811.87
• Purity:≥98%
• Appearance:Dark yellow to dark orange solid
• Melting Point:>127°C (dec.) (lit)
• Storage and Stability:Store at -20°C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap.